Authors
Latest:
Initiating an Antimicrobial Stewardship Program: The Costs and the BenefitsFor decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
The Intersection of Technology and Cancer Care: The Opportunity and Implications for Specialty PharmacyTechnological advancements empower patients to manage their own health.
Latest:
Pharmacist Management of Hyperkalemia: A Focus on Improving Clinical OutcomesDuring the 2020 virtual Directions in Pharmacy® conference, Todd Brothers, PharmD, BCCCP, BCPS, presented a comprehensive overview of hyperkalemia to optimize patient care with the use of safe and effective pharmacotherapeutic agents.
Latest:
Health Care Reform: A Game ChangerHealth Care Reform is here, right? That is true on one level, in that President Obama has signed a health care bill into law. But the signing of the bill only begins the process of change.
Latest:
Patient Adherence: Identifying Barriers and Defining SolutionsMajor patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Rx Product News Profile: A closer look at new FDA actions: Novartis' ValturnaThe FDA has approved Valturna (aliskiren/valsartan) to treat hypertension.
Latest:
New Therapies and the Role of Specialty Pharmacy ProvidersSpecialty pharmacies function as a valuable intermediary between stakeholders for the distribution of drug information, provision of exceptional care for complex patients, and engagement in postmarketing surveillance.
Latest:
Pharmacotherapy Timing in Heart Failure and Impact on Healthcare CostsThe findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Latest:
My Best Day as a Pharmacist: Indonesia: The Road Less TraveledThe winner of our second annual essay contest shares her experiences on a humanitarian mission in Indonesia.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
Adherence With Lipid-Lowering, Antihypertensive, and Diabetes MedicationsAdherence was examined among patients taking medications, individually and in combinations, to treat hypertension, hyperlipidemia, and/or diabetes.
Latest:
Enterprise Collaborations Help Meet ChallengesCommunity Health Network of Indianapolis and Walgreens are leveraging each other’s strengths to design and implement programs.
Latest:
Implementing Guideline-Recommended Therapy for Patients With CKD: Is Hope on the Horizon?This commentary addresses the possible reasons for treatment gaps between recommended therapy for patients with CKD, and the realities of current practices, and examines new developments that may bridge the gap.
Latest:
Asembia's Summit to Launch Another Transformative Year for Specialty PharmacyAsembia's 2020 Specialty Pharmacy Summit (May 3-7 at the Wynn & Encore in Las Vegas) will bring together stakeholders from across the industry to investigate challenges and collectively generate solutions.
Latest:
Does Medication Persistence in Diabetes Affect the Risk Of Hospitalization In The Short-Term?An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.
Latest:
Understanding the Evolving Landscape of Malignant MelanomaThis Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.
Latest:
Growing a Specialty Pharmacy Business Represents Opportunity for Today's Pharmacy OperationHow to "get into the game" as the health care environment continues to evolve is discussed. The opportunities abound for those willing to jump in.
Latest:
Pharmacists Are Transforming and Optimizing HIV TreatmentRegardless of a pharmacist’s practice site or type, they play an integral role in ensuring the treatment success of patients with HIV.
Latest:
Get PrEPared for HIV ProphylaxisExpansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy.
Latest:
340B Recertification: Annual Opportunity to Ensure 340B Program ComplianceThe 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.
Latest:
Approach Respiratory Illnesses RationallyWhen patients present with respiratory illnesses, pharmacists must assess factors such as comorbidities, symptoms and symptom control, medication history, and adverse effects.
